BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35508987)

  • 21. NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.
    Wang LL; Wan XY; Wang TL; Liu CQ; Zheng FM
    Med Oncol; 2022 Oct; 39(12):254. PubMed ID: 36224405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells.
    Cai H; Lu W; Zhang Y; Liu H; Wang Z; Shen Y
    J Cancer Res Ther; 2019; 15(7):1547-1552. PubMed ID: 31939436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase.
    Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim HY; Ahn JS; Kim SM; Kim MY; Hong JA; Seo MS; Lang F; Choi EJ; Park HS
    J Cell Sci; 2011 Jan; 124(Pt 1):100-12. PubMed ID: 21147854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
    Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
    Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
    [No Abstract]   [Full Text] [Related]  

  • 29. Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
    McGowan PM; Simedrea C; Ribot EJ; Foster PJ; Palmieri D; Steeg PS; Allan AL; Chambers AF
    Mol Cancer Res; 2011 Jul; 9(7):834-44. PubMed ID: 21665937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
    Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
    Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
    Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
    FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
    Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
    Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Notch1 signaling pathway activation on pancreatic cancer cell proliferation in vitro].
    Du X; Zhang S; Cheng Z; Li Y; Wang Z; Chen Z; Hu J; Zhou Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1494-8. PubMed ID: 24144754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro.
    Simmons MJ; Serra R; Hermance N; Kelliher MA
    Breast Cancer Res; 2012 Sep; 14(5):R126. PubMed ID: 22992387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
    Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
    BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optogenetic control of NOTCH1 signaling.
    Kałafut J; Czapiński J; Przybyszewska-Podstawka A; Czerwonka A; Odrzywolski A; Sahlgren C; Rivero-Müller A
    Cell Commun Signal; 2022 May; 20(1):67. PubMed ID: 35585598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
    Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
    Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
    Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
    Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.